The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe.
about
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV TherapyRegulated phosphorylation of a major UDP-glucuronosyltransferase isozyme by tyrosine kinases dictates endogenous substrate selection for detoxification.Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the InternatiEfavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected SubjectsSrc supports UDP-glucuronosyltransferase-2B7 detoxification of catechol estrogens associated with breast cancerClinical pharmacology, efficacy and safety of atazanavir: a review.Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders.Pharmacokinetic enhancers in HIV therapeutics.A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine ProductsLack of an Effect of Ritonavir Alone and Lopinavir-Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers.Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity.The effect of raltegravir on the glucuronidation of lamotrigine.
P2860
Q28080752-F4FFE4A2-2DB1-49A4-B12E-9600EB7D64BDQ34489142-1A9406AA-9648-433A-A5AD-823B71BB75D9Q36304546-E4222FB4-DAE8-40F8-AF4A-3C9CC523DF7EQ36715824-443FF7ED-2E23-468F-BE4B-8BBBD60DEF31Q37262571-4A47FA69-9638-47DB-BC1E-0112C2BA7AF7Q37622972-CC50DFA9-D314-4D60-B49F-C460D69A2FD1Q37973439-283DC557-632C-4BF7-8952-FB34D6FE3929Q38116456-04D43DD4-3253-461D-954E-535A2C8D3DEFQ38244014-FE70A820-D68D-44E0-A07D-B53C959B9F36Q38513275-68130255-B838-46F1-BE7A-F0E949CE265EQ40073748-40F17FDC-137C-4268-A27A-1BCEDA395BF9Q43204477-81A1E667-4535-467E-AFF1-4E0AE1524713Q43283574-CB56A5D1-99B5-4B86-97CA-EAA415CE2D89
P2860
The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@en
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@nl
type
label
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@en
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@nl
prefLabel
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@en
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@nl
P2093
P2860
P356
P1476
The effect of atazanavir and a ...... trigine as a phenotypic probe.
@en
P2093
D M Burger
G A Rongen
H Neisingh
N Van Ewijk
P Koopmans
P Van Uden
P2860
P304
P356
10.1038/CLPT.2008.106
P407
P577
2008-06-04T00:00:00Z